High-Sensitivity C-Reactive Protein
The most widely studied circulating inflammatory marker in cardiovascular epidemiology.
Primary Biological Role: Opsonin synthesized by hepatocytes in response to IL-6 stimulation, facilitating phagocytosis of dead cells.
Evidence Score
Evidence Dimension Breakdown
Overview
High-Sensitivity C-Reactive Protein (hs-CRP) is the most widely studied circulating inflammatory marker in cardiovascular epidemiology, though it is non-specific as to the source of inflammation. Unlike standard CRP assays used for detecting major infections, hs-CRP assays measure low-grade basal inflammation. The 2003 CDC/AHA scientific statement described hs-CRP tiers of <1.0, 1.0–3.0 and >3.0 mg/L as an optional adjunct to conventional risk factors in people at intermediate risk, and did not recommend hs-CRP screening of the general population.
Biological Mechanism
When upstream inflammatory cytokines—primarily Interleukin-6 (IL-6)—are released into circulation, they stimulate hepatic transcription of CRP. CRP acts as an innate immune pattern-recognition molecule, binding to phosphocholine on damaged cell membranes and microbial pathogens to activate the classical complement pathway and recruit phagocytes.
Clinical Trial & Outcome Evidence
Backed by hundreds of prospective cohort studies and massive randomized trials including the JUPITER trial (n=17,802) and CANTOS (n=10,061). hs-CRP predicts cardiovascular events, but whether lowering CRP itself changes outcomes has not been established: the drugs that lower it also act on other pathways — statins on LDL, canakinumab on IL-1β signalling.
Analytical Limitations & Confounders
hs-CRP is synthesized by the liver and is completely non-specific to tissue source. It rises transiently during acute viral or bacterial illness, physical trauma, or strenuous unaccustomed exercise, by as much as a thousandfold after major infection or trauma and far less after exercise (Gabay & Kushner 1999, PMID 9971870). Furthermore, baseline levels are associated with body mass index and adiposity, particularly visceral adipose tissue, which secretes the IL-6 that drives hepatic CRP synthesis.
Kinetics & Retesting Frequency
Hepatic CRP synthesis begins approximately 6–8 hours following an inflammatory trigger and peaks around 48 hours. Following resolution of the inflammatory stimulus, circulating CRP levels decline with a plasma half-life of ~19 hours, making it suitable for tracking multi-week therapeutic interventions. Within-subject coefficient of variation is high — median 44%, range 27–76% (Gough 2024, PMID 39485740) — so two measurements at least two weeks apart should be averaged.
Frequently Asked Questions
What does an elevated hs-CRP result mean, and what can raise it apart from cardiovascular risk?
An elevated hs-CRP indicates an active systemic acute-phase response, but it is non-specific as to the underlying anatomical source or etiology. Beyond cardiovascular risk, hs-CRP is raised by acute viral or bacterial infections, minor physical trauma, recent strenuous exercise, and adiposity—particularly visceral fat, which secretes IL-6 driving hepatic CRP synthesis. A single elevated reading should not be interpreted in isolation; guidelines recommend confirming with a second measurement at least two weeks apart when metabolically stable.
How often should hs-CRP be measured to track a wellness protocol?
Because hs-CRP has a ~19-hour half-life but reflects multi-week metabolic shifts, measuring it every 4 to 8 weeks provides an assessment of whether an intervention is dampening basal vascular inflammation. Serial measurements should be read against its high within-subject biological variability.
Biomarker Profile
- Class
- Acute-Phase Reactant
- Score
- 82/100
- Grade
- A−
Key Published Studies
- [1] JUPITER Trial — NEJM 2008 PMID: 18997196
- [2] CANTOS Trial — NEJM 2017 PMID: 28845751
- [3] AHA/CDC Scientific Statement on Inflammation Markers — Circulation 2003 PMID: 12551878
- [4] Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease — J Clin Invest 1993 PMID: 8473487
Related Biomarkers
Related Panel Patterns
Track Your Inflammation — Cohort Now Forming
Track your own inflammatory gene expression over time. Reserve your spot in the Inflammation Compass founding cohort today to lock in early pricing before the general public.